Hospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophrenia

Author： Kane John M.  

Publisher： Informa Healthcare

ISSN： 1369-6998

Source： Journal of Medical Economics, Vol.16, Iss.7, 2013-07, pp. : 917-925

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole

By Potkin Steven G.   Raoufinia Arash   Mallikaarjun Suresh   Bricmont Patricia   Peters-Strickland Timothy   Kasper William   Baker Ross A.   Eramo Anna   Sanchez Raymond   McQuade Robert  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1241-1251

Informa Healthcare

Access to resources Recommend Favorite

Once-monthly oral ibandronate compared with weekly oral alendronate in postmenopausal osteoporosis: results from the head-to-head MOTION study

By Miller Paul D.   Epstein Sol   Sedarati Farhad   Reginster Jean-Yves  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 207-213

Informa Healthcare

Access to resources Recommend Favorite

Switching from other antipsychotics to once-daily extended release quetiapine fumarate in patients with schizophrenia

By Ganesan S.   Agambaram V.   Randeree F.   Eggens I.   Huizar K.   Meulien D.    

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 21-32

Informa Healthcare

Access to resources Recommend Favorite

Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study

By Andrezina R.   Marcus R. N.   Oren D. A.   Manos G.   Stock E.   Carson W. H.   McQuade R. D.  

Current Medical Research and Opinion, Vol. 22, Iss. 11, 2006-11 ,pp. : 2209-2219

Informa Healthcare

Access to resources Recommend Favorite

A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA)

By Wolf Jürgen   Janssen Firmin   Lublin Henrik   Salokangas Raimo KR   Allain Hervé   Smeraldi Enrico   Bernardo Miguel   Millar Helen   Pans Miranda   Adelbrecht Christine   Laughton Jim   Werner Christian   Maier Wolfgang  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2313-2323

Informa Healthcare

Access to resources Recommend Favorite